ROGER KUAN

Mr. Kuan is currently a Partner with K&L Gates, a full-service international law firm with 45 offices worldwide. Prior to joining K&L Gates, Mr. Kuan served as director (IP counsel) at a multinational biotechnology company, where he managed a team of lawyers and agents to support the worldwide IP needs of the company’s life sciences tooling, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing product platforms.

Mr. Kuan has extensive prior professional experience in the Life Sciences Industry. Before transitioning his career into the legal industry, Mr. Kuan was employed with several Fortune 500 pharmaceutical, medical device, and chemical companies where he held professional positions in the R&D, Sales, Engineering, and Regulatory Affairs organizations.

Currently, Mr. Kuan focuses his practice on IP procurement and portfolio management for clients in the biotech, analytical instrumentation, software (with an emphasis on bioinformatics), bioprocessing/biomanufacturing, nucleic acid sequencing, chemical, medical device, molecular diagnostics, nanotechnology, optics, and semiconductor industries. He has over 10 years of experience in IP strategy and management, preparation and prosecution (utility/design patents, trademarks, trade dress), counseling and litigation, licensing and technology transactions, freedom-to-operate clearances, monetization, M&A due diligence, risk recognition & mitigation, dispute resolution, and FDA regulatory counseling.


Share This Post
Have your say!
00

Leave a Reply